Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 Trial of Trivalent Rotavirus Reassortment Vaccine in Infants
NCT01738074Phase 3Unknown
- Sponsor
- Henan Provincial Center for Disease Control and Prevention
- Start
- Aug 2012
- Primary completion
- Jun 2014
- Modality
- Live Attenuated Vaccines
01
Overview
Phase 3, randomised, double-blind trial of oral trivalent reassortant rotavirus live attenuated vaccine in rotavirus gastroenteritis (2 arms), sponsored by Henan Provincial Center for Disease Control and Prevention. Primary endpoints: Antibody titer differences in serum and Incidence differences of rotavirus diarrhea. Status: unknown.
02
Drugs
oral trivalent reassortant rotavirus live attenuated vaccine
03
Conditions
rotavirus gastroenteritis
Beyond the preview
Go deeper on NCT01738074.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01738074.